Gout and Metabolic Syndrome Association
Gout is associated with metabolic syndrome (MetS) in population-based data, with higher MetS prevalence among adults with gout than those without gout [1]. MetS is independently associated with gout after adjustment for key confounders in NHANES analyses [1].
Metabolic Syndrome Definitions Used in Association Studies
MetS is defined using established clinical criteria that incorporate multiple cardiometabolic abnormalities [1]. In NHANES-based gout analyses, MetS and individual MetS components were evaluated for association with gout status [1].
Direction and Magnitude of the Association
MetS prevalence was substantially higher in individuals with gout than in those without gout in NHANES 2007–2018 [1]. MetS remained independently associated with gout in multivariable models in NHANES 2007–2018 (OR=2.55, 95% CI 1.55–4.20) [1].
MetS Components Most Strongly Linked to Gout
Central obesity showed the strongest association with gout among MetS components in NHANES 2007–2018 (OR=2.44, 95% CI 1.55–3.85) [1]. Hypertension also showed a strong association with gout in NHANES 2007–2018 (OR=1.70, 95% CI 1.04–2.78) [1].
Clinical Framing of “Feature” Status
Gout should be classified as comorbid with MetS rather than as a defining or mandatory feature of MetS because MetS criteria are based on cardiometabolic abnormalities, not gout diagnosis [1]. Population data support inclusion of gout risk within the cardiometabolic clustering pattern captured by MetS [1].
Mechanistic and Epidemiologic Nuances
Serum uric acid and hyperuricemia show cardiometabolic clustering with established cardiovascular risk factors and MetS [2]. Associations of uric acid with subclinical atherosclerosis persisted after adjustment for MetS in a population-based cohort, supporting links between urate biology and cardiometabolic risk [2].
Research Evidence Base
The strongest direct evidence for the MetS–gout relationship in this query comes from NHANES 2007–2018, which evaluated MetS and MetS components against gout status in 28,130 adults with 1,279 gout cases [1]. A second large cohort analysis supports broader cardiometabolic clustering of uric acid with risk factors that overlap with MetS [2].
Targets for Clinical Assessment
Given the observed MetS–gout association, assessment for MetS components is clinically relevant in patients with gout based on NHANES findings [1]. Given the role of obesity and hypertension in the observed associations, weight-related and blood pressure evaluation are prioritized when gout coexists with MetS risk [1].
Conclusion
Gout is associated with metabolic syndrome and its components, with MetS independently linked to gout in NHANES 2007–2018 data [1].
Medication Recommendations
No gout-specific management recommendation is supported by the provided MetS–gout association evidence and this question does not request treatment guidance.
References
The association between gout and MetS is supported by NHANES-based analyses [1].